Human herpesvirus 7 induces the functional up-regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) coupled to TRAIL-R1 down-modulation in CD4+ T cells

Blood

Volumn 98, Issue 8, 2001, Pages 2474-2481

  Secchiero, Paola ^a,b,c,d   Mirandola, Prisco ^a,b,c,d   Zella, Davide ^a,b,c,d   Celeghini, Claudio ^a,b,c,d   Gonelli, Arianna ^a,b,c,d   Vitale, Marco ^a,b,c,d   Capitani, Silvano ^a,b,c,d   Zauli, Giorgio ^a,b,c,d  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

^c UNIVERSITY OF PARMA   (Italy)

^d UNIVERSITY OF MARYLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; FAS LIGAND; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; BYSTANDER EFFECT; CELL DEATH; CONTROLLED STUDY; CYTOTOXICITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 7; IMMUNE DEFICIENCY; IMMUNITY; LYMPHOBLASTOID CELL; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; VIRUS INFECTION; VIRUS PATHOGENESIS;

EID: 0035889159     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V98.8.2474     Document Type: Article

References (51)

1. + T cells. Proc Natl Acad Sci U S A. 1990;87:748-752.
2. Berneman ZN, Ablashi DV, Li G, et al. Human herpesvirus 7 is a T-lymphotropic virus and is related to, but significantly different from, human herpesvirus 6 and human cytomegalovirus. Proc Natl Acad Sci U S A. 1992;89:10552-10556.
3. Secchiero P, Nicholas J, Deng H, et al. Identification of human telomeric repeat motifs at the genome termini of human herpesvirus 7: structural analysis and heterogeneity. J Virol. 1995;68:8041-8045.
4. Nicholas J. Determination and analysis of the complete nucleotide sequence of human herpesvirus 7. J Virol. 1996;70:5975-5989.
5. Yoshikawa T, Asano Y, Kobayashi I, et al. Seroepidemiology of human herpesvirus 7 in healthy children and adults in Japan. J Med Virol. 1993; 41:319-323.
6. Clark DA, Freeland ML, Mackie LK, Jarrett RF, Onions DE. Prevalence of antibody to human herpesvirus 7 by age. J Infect Dis. 1993;168:251- 252.
7. Wyatt LS, Frenkel Z. Human herpesvirus 7 is a constitutive inhabitant of adult human saliva. J Virol. 1992;66:3206-3209.
8. Lusso P, Secchiero P, Crowley RW, Garzino-Demo A, Berneman ZN, Gallo RC. CD4 is a critical component of the receptor of human herpesvirus 7: interference with human immunodeficiency virus. Proc Natl Acad Sci U S A. 1994;91:3872-3876.
9. Secchiero P, Gibellini D, Flamand L, et al. Human herpesvirus 7 (HHV-7) induces the down-regulation of CD4 Ag in lymphoid T cells without affecting p561ck levels. J Immunol. 1997;159:3412-3423.
10. Leach CT. Human herpesvirus-6 and -7 infections in children: agents of roseola and other syndromes. Curr Opin Pediatr. 2000;12:269-274.
11. Bruns R, Muller CE, Wiersbitzky SK, Neipel F, Jager G. Clinical presentations of infection by the human herpesvirus-7 (HHV-7). Pediatr Hematol Oncol. 2000; 17:247-252.
12. Torigoe S, Koide W, Yamada M, Miyashiro E, Tanaka-Taya K, Yamanishi K. Human herpesvirus 7 infection associated with central nervous system manifestations. J Pediatr. 1996;129:301-305.
13. Black JB, Pellett PE. Human herpesvirus 7. Rev Med Virol. 1999;9:245-262.
14. Gautheret-Dejean A, Dejean O, Vastel L, et al. Human herpesvirus-6 and human herpesvirus-7 in the bone marrow from healthy subjects. Transplantation. 2000;69:1722-1733.
15. Peiris M. Human herpesvirus-7 (HHV-7) in transplant patients. Crit Rev Oncol Hematol. 2000;32:187-196.
16. Brennan DC, Storch GA, Singer GG, Lee L, Rueda J, Schnitzler MA. The prevalence of human herpesvirus-7 in renal transplant recipients is unaffected by oral or intravenous ganciclovir. J Infect Dis. 2000;181:1557-1561.
17. Kidd IM, Clark DA, Sabin CA, et al. Prospective study of human beta herpesviruses after renal transplantation: association of human herpesvirus 7 and cytomegalovirus co-infection with cytomegalovirus disease and increased rejection. Transplantation. 2000;69:2400-2404.
18. Mendez JC, Dockrell DH, Espy MJ, et al. Human beta-herpesvirus interactions in solid organ transplant recipients. J Infect Dis. 2001;183:179-184.
19. + hematopoietic progenitor cells by human herpesvirus 7 (HHV-7). Blood. 2000;96:126-131.
20. Chan PK, Peiris JS, Yuen KY, et al. Human herpesvirus 6 and human herpesvirus 7 infections in bone marrow transplant recipients. J Med Virol. 1997;53:295-305.
21. Secchiero P, Flamand L, Gibellini D, et al. Human herpesvirus 7 induces CD4(+) T-cell death by two distinct mechanisms: necrotic lysis in productively infected cells and apoptosis in uninfected or nonproductively infected cells. Blood. 1997;90:4502-4512.
22. + T cells. Blood. 1998;92:1685-1698.
23. + T cells infected with human herpesvirus 7. Blood. 1998;92:4521-4528.
24. + T cells. J Immunol. 1994;152:5768-5775.
25. Atedzoe BN, Menezes J, D'Addario M, Xu J, Ongradi J, Ahmad A. Modulatory effects on herpes virus-7 on cytokine synthesis and cell proliferation in human peripheral blood mononuclear cell cultures. J Leukoc Biol. 1999;66:822-828.
26. + T cells enhances human herpesvirus 7 replication and induction of cytopathic effects. Eur J Immunol. 1998;28:1587-1596.
27. Wiley SR, Schooley K, Smolak PJ, et al. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity. 1995;3:673-682.
28. Baker SJ, Reddy EP. Transducers of life and death: TNF receptor superfamily and associated proteins. Oncogene. 1996;12:1-9.
29. Mariani SM, Krammer PH. Differential regulation of TRAIL and CD95 ligand in transformed cells of the T and B lymphocyte lineage. Eur J Immunol. 1998;28:973-982.
30. Gruss HJ, Dower SK. Tumor necrosis factor ligand superfamily: involvement in the pathology of malignant lymphomas. Blood. 1995;85:3378-3404.
31. Ashkenazi A, Dixit VM. Apoptosis control by death and decoy receptors. Curr Opin Cell Biol. 1999;11:255-260.
32. Griffith TS, Rauch CT, Smolak PJ, et al. Functional analysis of TRAIL receptors using monoclonal antibodies. J Immunol. 1999;162:2597-2605.
33. Sprick MR, Weigand MA, Rieser E, et al. FADD/ MRT1 and caspase 8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2. Immunity. 2000; 12:599-609.
34. Kischkel FC, Lawrence DA, Chuntharapai A, Schow P, Kim J, Ashkenazi A. Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase 8 to death receptors 4 and 5. Immunity. 2000;12:611-620.
35. Foa'-Tommasi L, Avitabile E, Ke L, Campadelli-Flume G. Polyvalent and monoclonal antibodies identify major immunogenic proteins specific for human herpesvirus 7-infected cells and have weak cross- reactivity with human herpesvirus 6. J Gen Virol. 1994;75:2719-2727.
36. Matzinger P. The JAM test: a simple assay for DNA fragmentation and cell death. J Immunol Methods. 1991;145:185-192.
37. Zamai L, Secchiero P, Pierpaoli S, et al. TNF-related apoptosis-inducing ligand (TRAIL) as a negative regulator of normal human erythropoiesis. Blood. 2000;95:3716-3724.
38. Zauli G, Vitale M, Re MC, et al. In vitro exposure to human immunodeficiency virus type 1 induces apoptotic cell death of the factor-dependent TF-1 hematopoietic cell line. Blood. 1994;83:167-175.
39. Martinez-Lorenzo MJ, Anel A, Gamen S, et al. Activated human T cells release bioactive Fas ligand and APO2 ligand in microvesicles. J Immunol. 1999;163:1274-1281.
40. Kayagaki N, Yamaguchi N, Nakayama M, Eto H, Okumura K, Yagita H. Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosisinducing ligand (TRAIL) expression on human T cells: a novel mechanism for the antitumor effects of type I IFNs. J. Exp. Med. 1999;189:1451-1460.
41. Pan G, O'Rourke K, Chinnaiyan AM, et al. The receptor for the cytotoxic ligand TRAIL. Science. 1997;276:111-113.
42. Sheridan JP, Marsters SA, Pitti RM, et al. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science. 1997;277:818-821.
43. Song K, Chen Y, Goke R, et al. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is an inhibitor of autoimmune inflammation and cell cycle progression. J Exp Med. 2000;191:1095-1103.
44. Kimn K, Fisher MJ, Xu SQ, el-Deiry WS. Molecular determinants of response to TRAIL in killing of normal and cancer cells. Clin Cancer Res. 2000; 6:335-346.
45. Ward PL, Roizman B. Evasion and obstruction: the central strategy of the interaction of human herpesviruses with host defense. In: Medveczky PG, Friedman H, Bendinelli M, eds. Herpesviruses and Immunity. New York, NY: Plenum Press; 1998; 1 -32.
46. Sedger LM, Shows DM, Blanton RA, etal. IFNy mediates a novel antiviral activity through dynamic modulation of TRAIL and TRAIL receptor expression. J Immunol. 1999;163:920-926.
47. Raftery MJ, Behrens CK, Muller A, Krammer PK, Walczak PH, Schonrich G. Herpes simplex virus 1 infection of activated cytotoxic T cells: induction of fratricide as a mechanism of viral immune evasion. J Exp Med. 1999;190:1103-1113.
48. Kempf W, Muller B, Maurer R, Adams V, Campadelli Fiume G. Increased expression of human herpesvirus 7 in lymphoid organs of AIDS patients. J Clin Virol. 2000; 16:193-201.
49. Katsikis PD, Garcia-Ojeda ME, Torres-Roca JF, et al. Interleukin-1 beta converting enzyme-like protease involvement in Fas-induced and activation-induced peripheral blood T cell apoptosis in HIV infection: TNF-related apoptosis-inducing ligand can mediate activation-induced T cell death in HIV infection. J Exp Med. 1997;186:1365-1372.
50. Jeremias I, Herr I, Boehler T, Debatin KM. TRAIL/Apo-2-1igand-induced apoptosis in human T cells. EurJ Immunol. 1998;28:143-152.
51. Badley AD, Pilon AA, Landay A, Lynch DH. Mechanisms of HIV-associated lymphocyte apoptosis. Blood. 2000;96:2951-2964.